- HSD17B13 INHIBITORS AND USES THEREOF
-
Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH,
- -
-
Paragraph 00182-00183
(2021/10/22)
-
- PYRROLOPYRIMIDINECARBOXAMIDES
-
The compounds of Formula (I) wherein R1, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the N-oxides of the compounds and the salts thereof and the stereoisomers of the compounds, the salts, the N-oxides of
- -
-
Page/Page column 184-185
(2009/10/21)
-